000			01985 a2200553 4500
005			20250515012906.0
264		0	_c20060208
008			200602s 0 0 eng d
022			_a0009-9236
024	7		_a10.1016/j.clpt.2005.10.003 _2doi
040			_aNLM _beng _cNLM
100	1		_aLeitner, Judith M
245	0	0	_aRecombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia. _h[electronic resource]
260			_bClinical pharmacology and therapeutics _cJan 2006
300			_a23-34 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAnticoagulants
650	0	4	_aAntithrombins _xpharmacokinetics
650	0	4	_aBiomarkers
650	0	4	_aBlood Coagulation _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDouble-Blind Method
650	0	4	_aEndotoxemia _xchemically induced
650	0	4	_aFibrinolysis _xdrug effects
650	0	4	_aHemodynamics _xdrug effects
650	0	4	_aHumans
650	0	4	_aIn Vitro Techniques
650	0	4	_aInflammation Mediators _xblood
650	0	4	_aInterleukin-6 _xmetabolism
650	0	4	_aLeukocyte Count
650	0	4	_aLipopolysaccharides _xpharmacology
650	0	4	_aMale
650	0	4	_aPartial Thromboplastin Time
650	0	4	_aPeptide Fragments _xanalysis
650	0	4	_aProthrombin _xanalysis
650	0	4	_aProthrombin Time
650	0	4	_aRNA, Messenger _xbiosynthesis
650	0	4	_aRecombinant Proteins _xpharmacokinetics
650	0	4	_aThrombelastography
650	0	4	_aThrombin _xbiosynthesis
700	1		_aFirbas, Christa
700	1		_aMayr, Florian B
700	1		_aReiter, Rosemarie A
700	1		_aSteinlechner, Barbara
700	1		_aJilma, Bernd
773	0		_tClinical pharmacology and therapeutics _gvol. 79 _gno. 1 _gp. 23-34
856	4	0	_uhttps://doi.org/10.1016/j.clpt.2005.10.003 _zAvailable from publisher's website
999			_c16029692 _d16029692